Sun Pharmaceutical’s unit recalls over 17,000 units of antifungal medication in US

26 Dec 2025 Evaluate

Sun Pharmaceutical Industries’ unit -- Taro Pharmaceutical Industries is recalling over 17,000 units of an antifungal medication in the US due to manufacturing issues. The company is recalling the affected lot due to Failed Impurity/Degradation specifications. The company initiated the Class II nationwide recall on December 9 this year. As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.

Sun Pharmaceutical Industries completed the merger of Taro Pharmaceutical Industries with itself in a deal valued at $347.73 million last year.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1719.20 -18.30 (-1.05%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×